I. Paul Singh, MD
Show Description +
I. Paul Singh, MD, shares a case of iTrack canaloplasty (Nova Eye Medical) and Hydrus Microstent (Alcon) implantation. The patient experienced moderate primary open-angle glaucoma on three topical medications with 22 mm Hg preoperative IOP. One month postoperative, the patient is off all medications with 14 mm Hg IOP.
Financial Disclosure: Consultant (Alcon, Nova Eye Medical)
Posted: 11/26/2024
I. Paul Singh, MD
I. Paul Singh, MD, shares a case of iTrack canaloplasty (Nova Eye Medical) and Hydrus Microstent (Alcon) implantation. The patient experienced moderate primary open-angle glaucoma on three topical medications with 22 mm Hg preoperative IOP. One month postoperative, the patient is off all medications with 14 mm Hg IOP.
Financial Disclosure: Consultant (Alcon, Nova Eye Medical)
Posted: 11/26/2024
Sponsored Content
Sponsored Content
Sponsored Content
Sponsored Content
Please log in to leave a comment.